Navigation Links
Antigen Express' AE37 Cancer Vaccine Featured in Scientific American
Date:9/21/2011

y are used in discussing potential product applications, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not. Known risks and uncertainties include those identified from time to time in the reports filed by Generex with the Securities and Exchange Commission, which should be considered together with any forward-looking statement. No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements. Generex undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Generex cannot be sure when or if it will be permitted by regulatory agencies to undertake additional clinical trials or to commence any particular phase of clinical trials. Because of this, statements regarding the expected timing of clinical trials or ultimate regulatory approval cannot be regarded as actual predictions of when Generex will obtain regulatory approval for any "phase" of clinical trials or when it will obtain ultimate regulatory approval by a particular regulatory agency. Generex claims the protection of the safe harbor for forward-looking statements that is contained in the Private Securities Litigation Reform Act.


'/>"/>
SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. PharmAthene Response to DHHS Request for Proposals for Recombinant Protective Antigen Anthrax Vaccine Deemed Technically Acceptable and Within Competitive Range for Procurement Consideration
2. Pepscan Achieves a Breakthrough With CLIPS Immunogen Technology: Synthetic Peptide Antigen is Able to Induce Fully Functional Antibodies Against a Formerly Intractable GPCR Target CXCR7
3. Medicago succesfully expresses VLP antigen for A H1N1 strain
4. ImmunoVaccine Technologies Licenses Immunotopes Breast, Ovarian and Prostate Cancer Antigens
5. Antigen Discovery, Inc. Awarded Grant for Chlamydia Vaccine Development
6. ImaginAb, Inc. and BZL Biologics, LLC Conclude Licensing Agreement for Imaging Rights to huJ591/Prostate-Specific Membrane Antigen (PSMA)
7. PharmAthene Submits White Paper to BARDA for Advanced Development Funding for SparVax(TM) - Novel Recombinant Protective Antigen Anthrax Vaccine
8. BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines
9. Generex Announces Publication on Application of Antigen Express Technology for Early Detection of Type 1 Diabetes
10. Generex Announces Publication of Studies with the Mayo Clinic Confirming and Extending the Antigen Express Ii-Key Platform Technology
11. Generex Provides Update on Spinout of Antigen Express
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... -- Roka Bioscience, Inc. (NASDAQ: ROKA ), a molecular ... detection of foodborne pathogens,  today announced that Paul G. ... Lynch 2015 Health Care Conference on May 12 at 8:00am ... Wynn, Las Vegas NV. ... through the investor relations section of Roka Bioscience,s website at ...
(Date:5/5/2015)... 2015 Research and Markets ... of the "Separation Systems Market in ... Macromolecules which include protein, RNA, DNA ... broken into smaller molecules, during production of ... various advanced systems like centrifugation, liquid chromatography, ...
(Date:5/5/2015)... DIEGO , May 5, 2015  Renova™ ... for congestive heart failure and other chronic diseases, ... an independent analysis designed to reflect the healthcare ... time. This model will be used to characterize ... CHF, could have on those groups of patients ...
(Date:5/5/2015)... WASHINGTON, D.C., USA (PRWEB) May 05, 2015 ... export regulations covering a wide range of key photonics ... are hampering global competitiveness of U.S. industry. To help ... webinar on 12 May on the proposed ... governs the commodities covered by International Traffic in Arms ...
Breaking Biology Technology:Global Separation Systems Market in Biotechnology 2015-2019 - Trends and Forecasts for the $28 Billion Market 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 3Comments needed now from photonics industry on revisions of U.S. export rules 2Comments needed now from photonics industry on revisions of U.S. export rules 3Comments needed now from photonics industry on revisions of U.S. export rules 4
... A2A Adenosine Receptor Agonist Approved for Use in Identifying ... ... Astellas Pharma US, Inc. today,announced the commercial availability of ... a pharmacologic,stress agent in radionuclide MPI -- a test that ...
... JOSEPH, Mich., June 24 GeneGo, Inc., ... that VTT has licensed,MetaCore(TM). VTT develops novel ... diagnostics. The focus is in investigating,mechanisms of ... and exploration of the mechanism of action ...
... 24 Pinnacle Biologics, a private,full-service pharmaceutical and ... an agreement with Chiltern International, Inc. for the,activities ... Europe., James R. Miller, President & CEO ... agreement represents a significant step in the,process of ...
Cached Biology Technology:Astellas Launches Lexiscan(TM) (Regadenoson) Injection for Use as a Pharmacologic Stress Agent in Radionuclide Myocardial Perfusion Imaging (MPI) 2Astellas Launches Lexiscan(TM) (Regadenoson) Injection for Use as a Pharmacologic Stress Agent in Radionuclide Myocardial Perfusion Imaging (MPI) 3VTT Technical Research Centre of Finland Licenses MetaCore from GeneGo for Cancer Research and Diagnostics 2Pinnacle Biologics Announces Contract With Chiltern 2
(Date:4/8/2015)... N.C. , April 8, 2015  Infinisource, ... solutions and services, and Morpho, a leading supplier ... partnership to produce the market,s most advanced biometrically-enabled ... Infinisource,s iSolved NXG time clock is setting a ... and labor data for the small and mid-size ...
(Date:4/2/2015)... Germany , April 2, 2015 ... fingerprint tests DERMALOG by far outperforms the strongest ... always maintaining high accuracy, the system is capable ... Hence, the speed proves up to be ten ... faster than its runner-up performance.      ...
(Date:4/2/2015)... 2, 2015 According to preliminary ... to somewhat higher than 125 MSEK. This exceeds the ... 2014 that revenues for Q1 2015 would be in ... for Q4 2014. The operating result for the first ... complete interim report will as previously communicated be published ...
Breaking Biology News(10 mins):iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Revises Revenues for Q1 2015 2
... in partnership with Affymetrix, Inc., have designed a chip ... varieties and suggest ways to better manage them. By ... tissue of citrus ?genes that are associated with taste, ... information useful to researchers for rectifying existing problems and ...
... Dr. Peter Sarnow and a team of Stanford University scientists ... named miR-122, in order to replicate in cultured liver cells. ... amount of hepatitis C virus RNA was reduced by approximately ... potential to develop new antiviral agents against hepatitis C, the ...
... tiny viruses to build ultra-small "nanowire" structures for use ... few genes inside these viruses, the team was able ... a functional electronic device. , The goal of the ... and Yet-Ming Chiang, is to create batteries that cram ...
Cached Biology News:UCR researchers design chip that can improve citrus varieties 2UCR researchers design chip that can improve citrus varieties 3MIT researchers build tiny batteries with viruses 2MIT researchers build tiny batteries with viruses 3
The optional fixed lens, 105 mm, is for use with the VersaDoc imaging systems for imaging small samples at high resolution....
... The UltraClean Plant DNA Kit is ... total cellular DNA from plant cells and ... this kit replaces cumbersome DNA isolation procedures ... Using the UltraClean procedure, alcohol precipitation is ...
The sample holders for gels are used to hold gels in place in the multi-sample tray I, which is used with Molecular Imager FX imaging systems....
... Direct In Situ Apoptosis Detection ... situ by the direct TUNEL ... tagged with a directly labeled ... fluorescence staining for 40 samples ...
Biology Products: